The Secrets of a Happy Marriage:

Creating Complementary Partnerships

Sarah Berglas

Knowledge Mobilization Officer, CADTH

7th May 2013

Atypical antipsychotics in schizophrenia

Patients receive Expenditure

Reference: Ontario Drug Benefits Program, 2009 from IMS Brogan.

CADTH, Current Utilization Report, 2012.

11 Public drug plans spent $422 million on antipsychotics

Findings

High-dose strategies or combining atypical

antipsychotics with other antipsychotic agents

are not more effective and may be

more harmful than treatment with a

recommended dose of one antipsychotic agent.

Understand the receiver

Who can act on

the knowledge?

Why might they

be interested?

Where would

they look for

answers?

Psychiatrists

CPA

Needs

evidence to

inform clinical

practice &

education

CADTH

Needs to reach

prescribers &

be received

with credibility

Can offer extensive

analysis to answer

specific research

questions

Complementary collaboration with CPA

Respected, national

voice for Canada’s

4,000 psychiatrists

Tailor the message

Information you have

Information receiver

reallywants

Message

Message delivery

Contextualise

Listen & discuss

Offer practical

solutions

CMAJ.ca

Regularly read by

80% of Canada’s

69,000 physicians

Well-respected

Needs content

that is of high

quality,

engaging,

relevant &

current

CADTH

Needs to reach

prescribers &

be received

with credibility

Can offer regular

evidence based

analysis on wide

range of relevant

topics

Complementary collaboration with CMAJ

Beyond peer review

Find the

intersection

Tailor for

speciality &

region

…… nurses have a substantial role to play in building

a patent’s trust and willingness to receive prescribed

treatment. An accurate and open discussion of the

pros and cons of the medication offered is an

essential part of this process……

Yukon Registered Nurses Association, Dec 2012

…..What does this mean for community

pharmacists? If a patient with schizophrenia presents

with a high dose or combination AAP prescription,

consider discussing the script with the physician…..

Pharmacy Practice, July 2012

……however, clinicians may be very surprised to

learn how little evidence exists as to the safety and

efficacy of this practice in treating schizophrenia.

NL Medical Association newsletter, Sept 2012

Downloads from cadth.ca

0

50

100

150

200

250

300

350

400

Jan Feb Mar Apr May Jun Jul

Recs

Science

Atypical

Antipsychotics

Nu

mb

er

of d

ow

nlo

ad

s

Downloads in 2012

0

50

100

150

200

250

300

350

400

Jan Feb Mar Apr May Jun Jul

Recs

Science

CPA e-alert

CADTH

e-alert

CPA e-alert

CADTH

Symposium

Pharmacy Practice

Atypical

Antipsychotics

Nu

mb

er

of d

ow

nlo

ad

s

Downloads in 2012 & 2013

0

50

100

150

200

250

300

350

Aug Sept Oct Nov Dec Jan Feb

Recs

Science

2 conferences &

2 newsletters

2 newsletter

articles

1 newsletter

article

Atypical

Antipsychotics

Nu

mb

er

of d

ow

nlo

ad

s

‘What’s the Evidence?

Practicalities

Clear objectives

Openness

Trust

Time

www.cadth.ca/aaps

Project Team

Sumeet Singh

Dr Tarry Ahuja

Changhua Yu

Sam Verbrugghe

Chris Cameron

Karen Lee

David Kaunelis

Kristen Moulton

Janet Crain

Dr Janice Mann

Sarah Berglas

Pat Reynard

Sarah Neiman

McDonald

Adina Gottardi

Expert Committee

Dr Lisa Dolovich

Dr Mike Evans

Dr Michael Allen

Dr Scott Klarenback

Dr James Silvius

Dr Adil Virani

Panos Petrides

Cathy McNutt

Dr William Honer

Dr Gary Remington

Dr Richard Williams

Dr Heather Milliken

Liaison Officers

Ann Vosilla

Gabrielle

Zimmermann

Brendalynn Ens

Barb McCannell

Stephanie Smith

Lisa Farrell

Sheila Tucker

Joyce Thompson

Dawn Priestley

Jeannette Smith